Search by Drug Name or NDC
NDC 64764-0750-09 Trintellix 20 mg/1 Details
Trintellix 20 mg/1
Trintellix is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Takeda Pharmaceuticals America, Inc.. The primary component is VORTIOXETINE HYDROBROMIDE.
MedlinePlus Drug Summary
Vortioxetine is used to treat depression in adults. Vortioxetine is in a class of medications called serotonin modulators. It works mainly by increasing the amount of serotonin, a natural substance in the brain that helps maintain mental balance.
Related Packages: 64764-0750-09Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Vortioxetine
Product Information
| NDC | 64764-0750 |
|---|---|
| Product ID | 64764-750_9a2e06ef-8cc7-4f2a-ae57-fb965b37550b |
| Associated GPIs | 58120093100340 |
| GCN Sequence Number | 071512 |
| GCN Sequence Number Description | vortioxetine hydrobromide TABLET 20 MG ORAL |
| HIC3 | H8T |
| HIC3 Description | SSRI, SEROTONIN RECEPTOR MODULATOR ANTIDEPRESSANTS |
| GCN | 35349 |
| HICL Sequence Number | 040637 |
| HICL Sequence Number Description | VORTIOXETINE HYDROBROMIDE |
| Brand/Generic | Brand |
| Proprietary Name | Trintellix |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | vortioxetine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 20 |
| Active Ingredient Units | mg/1 |
| Substance Name | VORTIOXETINE HYDROBROMIDE |
| Labeler Name | Takeda Pharmaceuticals America, Inc. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA204447 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 64764-0750-09 (64764075009)
| NDC Package Code | 64764-750-09 |
|---|---|
| Billing NDC | 64764075009 |
| Package | 30 TABLET, FILM COATED in 1 BOTTLE (64764-750-09) |
| Marketing Start Date | 2013-10-02 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |